The owner of high-street pharmacy chain Boots is being bought by a private equity firm, and it will no longer be a public company listed on a stock exchange.
Walgreens Boots Alliance had agreed to a $23.7bn (£18.37bn) deal with private equity firm Sycamore Partners, as first reported by Sky News.
It means the business will no longer be a company with publicly traded shares listed on the Nasdaq stock exchange in New York.
Instead, for the first time in nearly a hundred years, it will be under the private ownership of the private equity firm, which specialises in retail.
Money blog: She created a six-figure business from a cardboard box
In return, shareholders will get $11.45 (£8.86) per share with the possibility of receiving another $3 (£2.32) per share if other business sale conditions are met.
Private equity firms acquire businesses, invest to improve financial performance and seek to then sell them for a profit.
Other high-street businesses, such as Morrisons and Asda supermarkets, have been acquired by private equity.
It’s unclear what the impact of the deal will be on Boots shops in the UK but a sale of that part of the business by new owners could be triggered.
The chain has struggled in recent years, announcing the closure of 300 stores in 2023 while Walgreens Boots Alliance shed 90% of its share price value since 2015.
A sell-off of the Boots arm of the business from the Walgreens Boots Alliance had been considered but was abandoned in 2022 amid torrid conditions in debt-financing markets.
Boots was acquired by Walgreens in 2014
Walgreens Boots Alliance was founded by John Boot in 1849, who sold herbal remedies.
It employs about 51,000 people in the UK in 1,800 pharmacies and opticians.
Boots, The Pharmacists’ Defence Association (PDA) and the Union of Shop, Distributive and Allied Workers (USDAW) have been contacted for comment.
